1. Araujo JD, Araujo JD Fo, Ciorlin E, et al. A terapia celular no tratamento da isquemia crítica dos membros inferiores. J Vasc Bras. 2005;4(4):357-65. http://dx.doi.org/10.1590/S1677-54492005000400011.

2. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313-9. PMid:18397751. http://dx.doi.org/10.1016/j.stem.2008.03.002.

3. Klimczak A, Kozlowska U. Mesenchymal stromal cells and tissuespecific progenitor cells: their role in tissue homeostasis. Stem Cells Int. 2015;2016:1-12.

4. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. PMid:16923606. http://dx.doi.org/10.1080/14653240600855905.

5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;6(5391):1145-7. PMid:9804556. http://dx.doi.org/10.1126/science.282.5391.1145.

6. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004;8(3):301-16. PMid:15491506. http://dx.doi.org/10.1111/j.1582-4934.2004.tb00320.x.

7. Ratajczak MZ, Zuba-Surma EK, Machalinski B, Kucia M. Bonemarrow-derived stem cells: our key to longevity? J Appl Genet. 2007;48(4):307-19. PMid:17998587. http://dx.doi.org/10.1007/BF03195227.

8. Yoshida WB. Angiogênese, arteriogênese e vasculogênese: tratamento do futuro para isquemia crítica do membro. J Vasc Bras. 2005;4(4):316-8. http://dx.doi.org/10.1590/S1677-54492005000400002.

9. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231(4736):397-400. PMid:2934816. http://dx.doi.org/10.1126/science.2934816.

10. Peck M, Gebhart D, Dusserre N, McAllister TN, L’Heureux N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs. 2011;195(1-2):144-58. PMid:21996786. http://dx.doi.org/10.1159/000331406.

11. Otero-Viñas M, Falanga V. Mesenchymal stem cells in chronic wounds: the spectrum from basic to advanced therapy. Adv Wound Care. 2016;5(4):149-63. PMid:27076993. http://dx.doi.org/10.1089/wound.2015.0627.

12. Liew A, Bhattacharya V, Shaw J, Stansby G. Cell therapy for critical limb ischemia: a meta-analysis of randomized controlled trials. Angiology. 2016;67(5):444-55. PMid:26195561. http://dx.doi.org/10.1177/0003319715595172.

13. Olausson M, Kuna VK, Travnikova G, et al. In vivo application of tissue-engineered veins using autologous peripheral whole blood: a proof of concept study. EBioMedicine. 2014;1(1):72-9. PMid:26137509. http://dx.doi.org/10.1016/j.ebiom.2014.09.001.

14. Bertanha M, Moroz A, Almeida R, et al. Tissue-engineered blood vessel substitute by reconstruction of endothelium using mesenchymal stem cells induced by platelet growth factors. J Vasc Surg. 2014;59(6):1677-85. PMid:23830317. http://dx.doi.org/10.1016/j.jvs.2013.05.032.

15. Bertanha M, Moroz A, Jaldin RG, et al. Morphofunctional characterization of decellularized vena cava as tissue engineering scaffolds. Exp Cell Res. 2014;326(1):103-11. PMid:24929113. http://dx.doi.org/10.1016/j.yexcr.2014.05.023.